On vaccination programs in the EU Member States: the case of the human papilloma virus [0.03%]
欧盟成员国的疫苗接种项目：以人类乳头瘤病毒为例
Reyes Lorente,Fernando Antonanzas
Reyes Lorente
Raul Brey,Jose Luis Pinto-Prades
Raul Brey
We provide more evidence on the functional relationship between willingness-to-pay for risk reductions and age (the senior discount). We overcome many of the limitations of previous literature that has dealt with this issue, namely, the inf...
The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program [0.03%]
针对瑞典初级保健和社区糖尿病预防计划中生活方式改变干预措施的成本效益分析
Anne Neumann,Lars Lindholm,Margareta Norberg et al.
Anne Neumann et al.
Background: Policymakers need to know the cost-effectiveness of interventions to prevent type 2 diabetes (T2D). The objective of this study was to estimate the cost-effectiveness of a T2D prevention initiative targeting w...
Out-migration and attrition of physicians and dentists before and after EU accession (2003 and 2011): the case of Hungary [0.03%]
欧盟东扩前后(2003年和2011年)匈牙利医师及牙医的外流与离职现象分析
Júlia Varga
Júlia Varga
This paper employs a large-scale, individual-level, panel dataset to analyse the effect of EU accession on the probability of out-migration on the part of Hungarian physicians and dentists between 2003 and 2011. The study uses event history...
The enigma of value: in search of affordable and accessible health care [0.03%]
价值之谜——探寻负担得起的、可及的医疗服务
Thomas D Szucs,Martina Weiss,Guido Klaus
Thomas D Szucs
In times of shrinking resources and pharmaceutical breakthrough situations, our value-assessing systems are stretched to their very limits. Assessing value is highly complex. Current value-assessment systems risk neglecting important factor...
Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients [0.03%]
老年用药负担分析及药学监护的成本效益分析
Amaia Malet-Larrea,Estíbaliz Goyenechea,Miguel A Gastelurrutia et al.
Amaia Malet-Larrea et al.
Background: Drug related problems have a significant clinical and economic burden on patients and the healthcare system. Medication review with follow-up (MRF) is a professional pharmacy service aimed at improving patient...
Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth [0.03%]
早产的费用效果分析：早期、晚期早产与足月分娩后婴儿出生后的前三年医疗保健费用比较
Josephine Jacob,Moritz Lehne,Andrea Mischker et al.
Josephine Jacob et al.
Preterm birth is one of the main causes for infant morbidity and mortality. Apart from negative health outcomes, preterm birth also produces significant health care expenditures. This study evaluates the costs associated with preterm birth ...
Sarah Neubauer,Kristine Kreis,Mike Klora et al.
Sarah Neubauer et al.
A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole [0.03%]
一种模拟不同费用分摊设计下控制成本的激励的方法及其在首欧元免赔额和缺口期中的应用
D Cattel,R C van Kleef,R C J A van Vliet
D Cattel
Many health insurance schemes include deductibles to provide consumers with cost containment incentives (CCI) and to counteract moral hazard. Policymakers are faced with choices on the implementation of a specific cost sharing design. One o...
The impact of minimum wages on population health: evidence from 24 OECD countries [0.03%]
最低工资对人群健康的影响：来自24个经合组织国家的证据
Otto Lenhart
Otto Lenhart
This study examines the relationship between minimum wages and several measures of population health by analyzing data from 24 OECD countries for a time period of 31 years. Specifically, I test for health effects as a result of within-count...